Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
NovaBay Pharmaceuticals to Hold Third Quarter 2020 Conference Call on November…
Clinical
OliX Pharmaceuticals Announces FDA Clearance of the IND to Evaluate the…
Commercial
BioSpace Movers & Shakers, Oct. 30
Commercial
Q32 Stays Busy with $60 Million Series B and First Dose…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide…
Commercial
Oyster Point Pharma to Report Third Quarter 2020 Financial Results on…
Clinical
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Clinical
Trevena, Inc. Announces DEA Scheduling of OLINVYK (oliceridine) injection – FirstWord…
Home
Therapy areas
Musculoskeletal
Musculoskeletal
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Musculoskeletal
Terumo’s PLAJEX Provides a Solution for a New Osteoporosis Treatment Developed and Manufactured on Contract
Firstwordpharma News
-
December 11, 2019
Musculoskeletal
Fulcrum Therapeutics Licenses Failed GSK Drug for Possible Muscular Dystrophy Indication
Musculoskeletal
Study links Celebrex, heart valve calcification after earlier research declared drug safe
Musculoskeletal
The delicate balance of treating growing but brittle bones
Musculoskeletal
Drug shows promise to treat diet-induced osteoarthritis
Musculoskeletal
Despite concerns, opioids remain legitimate pain medications, says Health Canada ...
Firstwordpharma News
-
December 7, 2018
0
- Advertisement -
MOST POPULAR
Altaire Issues Correction To 07.03.2019 Recall Announcement For OTC Products Sold...
July 15, 2019
Paratek Announces Top Line Results of Phase 2 Clinical Studies of...
October 31, 2019
Lilly To Participate in SVB Leerink Global Healthcare Conference
February 21, 2020
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
October 31, 2020
Load more
HOT NEWS
Commercial
Repligen to Report Second Quarter 2020 Financial Results Nasdaq:RGEN
Commercial
CTI BioPharma to Present at Oppenheimer’s 29th Annual Healthcare Conference on...
Deals
Scandion Oncology signs collaboration agreement with University of Copenhagen regarding co-development...
Immuno-inflammation
Janssen Presents New Four-Year TREMFYA (guselkumab) Data Demonstrating Maintained Rates of...
